Comparative outcomes of microsurgical dorsal root entry zone lesioning (DREZotomy) for intractable neuropathic pain in spinal cord and cauda equina injuries
- PMID: 39747752
- PMCID: PMC11695575
- DOI: 10.1007/s10143-024-03136-y
Comparative outcomes of microsurgical dorsal root entry zone lesioning (DREZotomy) for intractable neuropathic pain in spinal cord and cauda equina injuries
Abstract
Treatment of neuropathic pain in patients with spinal cord injury (SCI) and cauda equina injury (CEI) remains challenging. Dorsal root entry zone lesioning (DREZL) or DREZotomy is a viable surgical option for refractory cases. This study aimed to compare DREZL surgical outcomes between patients with SCI and those with CEI and to identify predictors of postoperative pain relief. We retrospectively analyzed 12 patients (6 with SCI and 6 with CEI) with intractable neuropathic pain who underwent DREZL. The data collected were demographic characteristics, pain distribution, and outcomes assessed by numeric pain rating scores. Variables and percentages of pain improvement at 1 year and long-term were statistically compared between the SCI and CEI groups. The demographic characteristics and percentage of patients who experienced pain improvement at 1 year postoperatively did not differ between the groups. Compared with the SCI group, the CEI group presented significantly better long-term pain reduction (p = 0.020) and favorable operative outcomes (p = 0.015). Patients with border zone pain had significantly better long-term pain relief and outcomes than did those with diffuse pain (p = 0.008 and p = 0.010, respectively). Recurrent pain after DREZL occurred in the SCI group but not in the CEI group. DREZL provided superior pain relief in patients with CEI. The presence of border zone pain predicted favorable outcomes. CEI patients or SCI patients with border zone pain are good surgical candidates for DREZL, whereas SCI patients with below-injury diffuse pain are poor candidates.
Keywords: Cauda equina injury; DREZotomy; Dorsal root entry zone lesioning; Neuropathic pain; Spinal cord injury; Surgical outcome.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethical approval: This study was ethically approved by the Siriraj Institutional Review Board, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand (Si-372/2024). Patient data were kept confidential per the Declaration of Helsinki. Consent to participate: Written informed consent to participate was not required for this retrospective study. Consent for publication: No personally identifiable data from research participants are disclosed in this article. Written informed consent for publication was not needed. Competing interests: The authors declare no competing interests.
Figures
References
-
- Alles SRA, Smith PA (2018) Etiology and pharmacology of neuropathic pain. Pharmacol Rev 70:315–347 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
